Pressure BioSciences, Inc. (PBIO) Financials
PBIO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2024 | 6.9 million | 44.1 million |
| March 31, 2024 | 7.0 million | 45.1 million |
| Dec. 31, 2023 | 1.0 million | 33.8 million |
| Sept. 30, 2023 | 1.6 million | 30.2 million |
PBIO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2024 | -705912 | 82528 |
| March 31, 2024 | -1.9 million | 318892 |
| Dec. 31, 2023 | -8.6 million | 2.4 million |
| Sept. 30, 2023 | -736932 | 140622 |
PBIO Net Income
No data available :(
PBIO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2024 | 14253 | 160485 | 566342 |
| March 31, 2024 | 3220 | 161182 | 584547 |
| Dec. 31, 2023 | 81279 | 161864 | 127856 |
| Sept. 30, 2023 | 5263 | 162522 | 137546 |
PBIO Shares Outstanding
PBIO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2024 | - | 296146 | 1.7 million | 156892 |
| March 31, 2024 | - | 272023 | 1.3 million | 130173 |
| Dec. 31, 2023 | 7.5 million | 362717 | 3.1 million | 192912 |
| Sept. 30, 2023 | 4495 | 288345 | 1.2 million | 157773 |
PBIO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2024 | 421792 | -421.4 million |
| March 31, 2024 | 349257 | 233310 |
| Dec. 31, 2023 | 312351 | 333517 |
| Sept. 30, 2023 | 413009 | 642466 |
PBIO Revenue by Segment
Graph available only for paid members. Upgrade to see it.
PBIO
Price: $0
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.83 USD
P/E Ratio: -0.01
Exchange: OEM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 49100
Ebitda: -3.8 millionMarket Capitalization: 200739